Nisa Investment Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$9.17 - $19.29 $201 - $424	-22 Reduced 5.99%	345 $3,000
Q4 2022 Feb 02, 2023	BUY	$11.61 - $16.11 $255 - $354	22 Added 6.38%	367 $5,000
Q4 2021 Feb 03, 2022	SELL	$14.28 - $19.53 $52,836 - $72,261	-3,700 Reduced 91.47%	345 $6,000
Q2 2021 Aug 06, 2021	BUY	$15.46 - $24.5 $57,202 - $90,650	3,700 Added 1072.46%	4,045 $81,000
Q4 2020 Jan 25, 2021	SELL	$24.48 - $42.47 $20,808 - $36,099	-850 Reduced 71.13%	345 $9,000
Q3 2020 Oct 20, 2020	BUY	$39.09 - $53.44 $39,090 - $53,440	1,000 Added 512.82%	1,195 $50,000
Q2 2020 Jul 27, 2020	BUY	$46.7 - $92.04 $700 - $1,380	15 Added 8.33%	195 $9,000
Q1 2020 Apr 17, 2020	SELL	$48.35 - $118.68 $5,802 - $14,241	-120 Reduced 40.0%	180 $11,000
Q4 2019 Jan 17, 2020	BUY	$57.36 - $124.1 $11,472 - $24,820	200 Added 200.0%	300 $37,000
Q3 2018 Oct 16, 2018	BUY	$88.49 - $127.55 $8,849 - $12,755	100 New	100 $13,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.